Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
If you lose a seed phrase, follow proven recovery steps and establish safeguards to regain access while preventing further risk.
21,102 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
OpenAI has begun allowing users to link bank accounts to ChatGPT, turning the chatbot into a real-time financial assi...
A fresh look at IRA activity in 2025-26 shows the $7,500 limit almost nobody hits, with average contributions far bel...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Ultra-safe funds show shrinking income while principal remains flat, challenging the notion of a truly safe retiremen...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
Homebuyers in 2026 face evolving lending rules and fluctuating rates. This explainer outlines how to qualify for a mo...
The data center story now hinges on AI workloads and energy efficiency. This clear, practical comparison of Applied D...
As earnings season arrives, investors focus on Axon’s path to durable growth. This article breaks down axon (axon) 20...
A 49-year-old military veteran weighs early retirement with a guaranteed $8,000 monthly pension and a $1.2 million ne...
Dutch Bros is pursuing aggressive growth inside its existing markets, aiming to dramatically increase store counts an...